PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34950184-0	2021	Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma.	gadolinium ethoxybenzyl DTPA	70-81	CD274 molecule	Homo sapiens	136-141	
34950184-12	2021	The intensity of the nodule on the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI is a promising imaging biomarker for predicting unfavorable response with anti-PD-1/PD-L1 monotherapy in patients with HCC.	gadolinium ethoxybenzyl DTPA	58-69	CD274 molecule	Homo sapiens	167-172	
33993366-0	2022	Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.	gadolinium ethoxybenzyl DTPA	20-34	CD274 molecule	Homo sapiens	106-111	
33993366-2	2022	We aimed to determine the ability of preoperative gadoxetic acid-enhanced magnetic resonance imaging (MRI) findings to predict CD8 cell density and PD-L1 expression in HCC.	gadolinium ethoxybenzyl DTPA	50-64	CD274 molecule	Homo sapiens	148-153